Summary of Significant Accounting Policies (Details) - Schedule of accrued expenses - USD ($) |
Sep. 30, 2020 |
Dec. 31, 2019 |
|---|---|---|
| Schedule of accrued expenses [Abstract] | ||
| Professional and consulting fees | $ 618,472 | $ 214,777 |
| Accrued payroll and payroll taxes | 1,603,245 | 1,287,047 |
| Clinical trial related | 687 | 2,435,953 |
| Manufacturing development related | 230,248 | 806,032 |
| Other | 64,189 | 54,666 |
| Total | $ 2,516,841 | $ 4,798,475 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Fair value portion of accrued expenses. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|